Stocks YSXT Financial statements
Financial statementsYSX Tech Co., Ltd financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data YSX Tech Co., Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2023 | FY2025 | FY2025 | FY2026 | |
|---|---|---|---|---|
| Revenue | 49.2 | 58.5 | 71.5 | 83.5 |
| Cost of revenue | 42.1 | 51.6 | 64.1 | 76.3 |
| Gross profit | 7.15 | 6.96 | 7.39 | 7.19 |
| Research and development | 0.25 | 0.23 | 0.24 | 0.25 |
| Selling and marketing | 0.12 | 0.11 | 0.12 | 0.1 |
| General and administrative | 1.12 | 1.62 | 2.23 | 1.48 |
| Operating expenses | 1.49 | 1.96 | 2.59 | 3.65 |
| Operating income | 5.66 | 5 | 4.8 | 3.54 |
| Interest expense | 0.08 | 0.14 | 0.16 | 0.25 |
| Interest income | 0 | 0 | 0 | 0 |
| Other non-operating income | 0.28 | 0.1 | -0.1 | 0.31 |
| Pre-tax income | 5.94 | 5.1 | 4.7 | 3.85 |
| Income tax | 1.04 | 0.54 | 0.68 | 1.05 |
| Net income | 4.9 | 4.57 | 4.02 | 2.8 |
| EBITDA | 5.69 | 5.03 | 4.83 | 3.59 |
| EPS, basic | 0.22 | 0.21 | 0.18 | 0.11 |
| EPS, diluted | 0.22 | 0.21 | 0.18 | 0.11 |
| Shares, basic (weighted) | 22 | 22 | 22.4 | 25.8 |
| Shares, diluted (weighted) | 22 | 22 | 22.4 | 25.8 |
Balance sheet
| FY2023 | FY2025 | FY2025 | FY2026 | |
|---|---|---|---|---|
| Cash and equivalents | 3.39 | 4.28 | 7.11 | 5.89 |
| Short-term investments | 1.46 | 2.1 | ||
| Other current assets | 0.85 | 0.17 | 0.15 | |
| Total current assets | 27.5 | 39.9 | 54.3 | |
| Property, plant and equipment | 0.05 | 0.19 | 0.25 | |
| Lease right-of-use assets | 0.22 | 0.14 | 0.28 | |
| Total assets | 27.9 | 40.3 | 55 | |
| Accounts payable | 1.53 | 2.26 | 7.32 | |
| Deferred revenue | 0.01 | 0 | 0.3 | |
| Total current liabilities | 7.21 | 11.4 | 19.5 | |
| Lease liabilities | 0.16 | 0.07 | 0.22 | |
| Total liabilities | 9.24 | 12.7 | 21.3 | |
| Paid-in capital | 5.35 | 10.4 | 12.2 | |
| Retained earnings | 13.7 | 17.6 | 20.1 | |
| Other comprehensive income | -1.18 | -1.28 | 0.14 | |
| Shareholders' equity | 14.8 | 18.6 | 27.6 | 33.7 |
| Total equity | 14.8 | 18.6 | 27.6 | 33.7 |
| Total liabilities and equity | 27.9 | 40.3 | 55 | |
| Shares outstanding | 22 | 22 | 23.4 | 24.1 |
Cash flow statement
| FY2023 | FY2025 | FY2025 | FY2026 | |
|---|---|---|---|---|
| Net income | 4.9 | 4.57 | 4.02 | 2.8 |
| Depreciation and amortization | 0.03 | 0.03 | 0.03 | 0.05 |
| Stock-based compensation | 1.82 | |||
| Deferred income tax | 0.04 | 0.02 | -0.06 | 0.03 |
| Change in receivables | 0.15 | -2.94 | -8.81 | -5.98 |
| Cash from operations | 1.03 | -0.69 | -6.49 | -2.69 |
| Capital expenditures | -0 | -0.17 | -0.09 | |
| Purchases of investments | -3.65 | -2.1 | ||
| Cash from investing | -1.98 | -0.23 | 1.94 | -0.09 |
| Cash from financing | 0.48 | 1.99 | 7.25 | 1.67 |
| Exchange rate effect | -0.3 | -0.17 | 0.12 | -0.11 |
| Free cash flow | -0.7 | -6.66 | -2.77 | |
| Interest paid | 0.08 | 0.14 | 0.16 | 0.25 |
| Income taxes paid | 0.02 | 0.04 | 0.03 | 0.04 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 8.6% | Gross profit / revenue. |
| Operating margin | 4.2% | Operating income / revenue. |
| EBITDA margin | 4.3% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 4.6% | Pre-tax income / revenue. |
| Net margin | 3.4% | Net income / revenue. |
| FCF margin | -3.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -3.2% | Cash from operations / revenue. |
| Effective tax rate | 27.2% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 9.2% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 5.9% | Net income / average total assets. |
| Return on invested capital (ROIC) | 10.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 0.3% | Research and development expense / revenue. |
| Stock-based pay / revenue | 2.2% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.1% | Capital expenditures / revenue. |
| D&A / revenue | 0.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 16.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 19.2% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -2.6% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 0.2% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | -26.2% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -14.5% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -25.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -14.2% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | -30.3% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -17.0% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | -38.9% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -20.6% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | 21.9% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 31.5% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 36.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Share count change, 1y | 15.0% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 5.4% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.79x | Current assets / current liabilities. |
| Quick ratio | 0.30x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.30x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 38.7% | Total liabilities / total assets. |
| Interest coverage | 14.1x | Operating income / interest expense. |
| Working capital | $34.8M | Current assets - current liabilities. |
| Tangible book value | $33.7M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.75x | Revenue / average total assets. |
| Fixed asset turnover | 379x | Revenue / average property, plant and equipment. |
| Days payables | 23 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | -98.9% | Free cash flow / net income, when net income is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.11 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.11 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $3.24 | Revenue / diluted weighted shares. |
| FCF per share | -$0.11 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$0.10 | Cash from operations / diluted weighted shares. |
| Book value per share | $1.40 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $1.40 | Tangible book value / shares outstanding. |
| Cash per share | $0.24 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $41.4M | Share price x shares outstanding. |
| Enterprise value | $35.6M | Market cap + total debt - cash - short-term investments. |
| P/E | 14.8x | Market cap / net income. Only when net income is positive. |
| P/S | 0.50x | Market cap / revenue. |
| P/B | 1.23x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 1.23x | Market cap / tangible book value, when positive. |
| EV/Sales | 0.43x | Enterprise value / revenue. |
| EV/EBIT | 10.0x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 9.90x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -6.7% | Free cash flow / market cap. |
| Earnings yield | 6.8% | Net income / market cap (the inverse of P/E). |
What was YSX Tech Co., Ltd's revenue in fiscal 2026?
YSX Tech Co., Ltd reported revenue of $83.5M for fiscal 2026, 16.8% higher than the year before.
Was YSX Tech Co., Ltd profitable in fiscal 2026?
Yes. Net income was $2.8M, a net margin of 3.4%.
How much free cash flow did YSX Tech Co., Ltd generate in fiscal 2026?
Cash from operations of $2.7M minus capital expenditures of $88.7K left free cash flow of -$2.8M.